Latest News
Indaptus Therapeutics, Inc.
- Indaptus Therapeutics, Inc. Estimates – BOATS:INDP
- Form 13D/A Indaptus Therapeutics For: 22 October By Investing.com
- A placement cuts a holder’s percentage stake in Indaptus Therapeutics (INDP) without the holder selling.
- The CEO’s ownership share fell without a sale at Indaptus Therapeutics (INDP).
- Ting Yang Reduces Indaptus Therapeutics Stake to 6.48% Following Share Sales and Private Placement
- Why Are Teknova (NASDAQ:TKNO), Indaptus (NASDAQ:INDP), Chaince (NASDAQ:CD) and Exascale (NASDAQ:XLAB) Moving on Funding?
- Indaptus Therapeutics Closes $24 Million Private Placement, Issues 20.3 Million Shares
- Indaptus Therapeutics completes $24 million private placement of common stock
- Form 8K Indaptus Therapeutics Inc For: 20 October By Investing.com
- Indaptus Therapeutics, Inc. announced that it has received $23.999989 million in funding
- Indaptus Therapeutics (INDP) Slips 1.99% to $2.46, Drifting Toward Support at $2.34 - Rip Sell Trade
- Indaptus Therapeutics Extends $24 Million Private Placement Closing to Oct. 16
Headlines from the last 30 days, linking to the original publishers. See all market news →